Cardio Diagnostics Holdings Stock Price, News & Analysis
Company Description
Cardio Diagnostics Holdings (NASDAQ: CDIOW) is a publicly traded company in the In Vitro & in Vivo Diagnostic Substances sector.
CDIOW stock has declined 38.1% over the past year. Shares last traded at $0.0156.
On a trailing twelve-month basis, Cardio Diagnostics Holdings reported revenue of $15K with net income of -$6.5M and diluted earnings per share of $-3.71. The company operates at a net profit margin of -43832.5%.
This page provides a comprehensive overview of CDIOW stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Cardio Diagnostics Holdings (CDIOW) stock last traded at $0.0156. Over the past 12 months, the stock has lost 38.1%.
Latest News
SEC Filings
Cardio Diagnostics Holdings has filed 5 recent SEC filings, including 4 Form 4, 1 Form 8-K. The most recent filing was submitted on April 2, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CDIOW SEC filings →
Financial Highlights
Cardio Diagnostics Holdings generated $15K in revenue over the trailing twelve months, operating income reached -$6.5M (-43737.5% operating margin), and net income was -$6.5M, reflecting a -43832.5% net profit margin. Diluted earnings per share stood at $-3.71. The company generated -$5.7M in operating cash flow. With a current ratio of 9.79, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Cardio Diagnostics Holdings (CDIOW) currently stands at 3.9 thousand shares, down 46.5% from the previous reporting period. Over the past 12 months, short interest has increased by 200.2%.
Days to Cover History
Days to cover for Cardio Diagnostics Holdings (CDIOW) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CDIOW Company Profile & Sector Positioning
Cardio Diagnostics Holdings (CDIOW) operates in the In Vitro & in Vivo Diagnostic Substances sector and is listed on the NASDAQ.